Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
05/2006
05/17/2006CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/16/2006US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
05/16/2006US7045527 Piperidine derivatives
05/11/2006WO2006050435A1 Heterocyclical chromophore architectures
05/11/2006WO2005103039A8 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
05/11/2006US20060100231 Amorphous clopidogrel hydrogen sulfate
05/11/2006CA2584869A1 Heterocyclical chromophore architectures
05/11/2006CA2584792A1 Heterocyclical chromophore architectures
05/10/2006EP1655294A2 Chromene compound
05/10/2006EP1655293A2 Chromene compound
05/10/2006EP1654257A1 Aminopyrones and their use as atm inhibitors
05/10/2006EP1049700B9 Chemokine receptor antagonists and methods of use therefor
05/10/2006CN1771235A Isoxazole compounds
05/10/2006CN1771037A Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
05/10/2006CN1769283A Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/10/2006CN1769282A Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/10/2006CN1769281A Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
05/10/2006CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase
05/09/2006US7041819 Separation technology, environmental remediation, and biomedical applications such as dialysis and drug delivery
05/09/2006US7041763 Photochromic polymers and methods of synthesizing same
05/09/2006US7041695 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
05/04/2006WO2006047397A1 Thieno-pyrimidine compounds having fungicidal activity
05/04/2006WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
05/04/2006WO2006047124A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
05/04/2006WO2006047017A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
05/04/2006WO2006046778A1 3-carbamoyl-2-pyridone derivative
05/04/2006WO2006046040A1 Pharmaceutical compounds
05/04/2006WO2006046035A1 Pharmaceutical compounds
05/04/2006WO2006046031A1 Pharmaceutical compounds
05/04/2006WO2006031893A3 Fused thiophenes, methods for making fused thiophenes, and uses thereof
05/04/2006WO2005049581A8 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
05/04/2006US20060094776 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
05/04/2006US20060094746 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-hydroxythieno[2,3-c]isoquin-5(4H)-one, used for treating tumor diseases, leukaemia, sarcoma, tissue damage due to ischemia and reperfusion, inflammatory disease, retinal ischemia or brain trauma
05/04/2006CA2585112A1 Fused pyrimidines and their use as inhibitors of pi3k
05/04/2006CA2585089A1 Fused pyrimidines and their use as inhibitors of pi3k
05/04/2006CA2583550A1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
05/04/2006CA2581223A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
05/04/2006CA2580690A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
05/03/2006EP1652849A1 Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
05/03/2006EP1652532A1 Medicinal composition
05/03/2006EP1651652A1 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
05/03/2006EP1651646A1 A novel process for the manufacture of (+)-(s)-clopidogrel bisulfate form-i
05/03/2006EP1543011B1 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
05/03/2006EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof
05/03/2006CN1768065A Thienopyrimidine compound and use of the same
05/03/2006CN1768064A Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
05/03/2006CN1768036A Indolone-acetamide derivatives, processes for preparing them and their uses
05/03/2006CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents)
05/02/2006US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists
05/02/2006US7037915 fused thienopyrimidine compounds useful as phosphatidylinositol 3-kinase inhibitors and carcinostatic agents
05/02/2006CA2125820C Process for producing thiophene derivative
04/2006
04/27/2006WO2006044826A2 Thiophens and their use as anti-tumor agents
04/27/2006WO2006044524A1 Benzothieno’2,3-d! pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases
04/27/2006WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring
04/27/2006WO2006042481A1 Method of obtaining clopidogrel
04/27/2006WO2006025069A3 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
04/27/2006US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics
04/26/2006EP1650235A1 Vinyl monomer, polymer derived from such monomer, and a light-emitting device using such polymer
04/26/2006EP1650202A1 4,5-DIHYDRONAPHTHO [1,2-b] THIOPHENE DERIVATIVE
04/26/2006EP1648921A2 Libraries containing heterocyclic organic molecules prepared through intramolecular formation of n-acyliminium ions
04/26/2006EP1648905A1 Thienopyridine and furopyridine kinase inhibitors
04/26/2006EP1648904A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands
04/26/2006EP1648903A2 Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
04/26/2006EP1648864A1 Photochromic diarylethene-containing coordination compounds and the production thereof
04/26/2006EP1648408A1 Azepine derivatives as pharmaceutical agents
04/26/2006EP1409485B1 Immunomodulating compounds
04/26/2006CN1253454C Beta-carboline and thio-analogues subsitituted by amino-acid radical/acyl, preparing method and application thereof
04/26/2006CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines
04/26/2006CN1253448C Preparation of thiophene monomer and its polymerizing method
04/26/2006CN1253441C Protease inhibitors
04/25/2006US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease
04/25/2006US7034150 Processes for the preparation of carbapenem-type antibacterial agents
04/25/2006US7034047 Triazole derivative
04/25/2006US7034039 Fused heterocyclic compounds
04/25/2006US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality
04/20/2006WO2006041985A2 Thienopyridinone compounds and methods of treatment
04/20/2006WO2006040966A1 Aromatic-ring-fused pyrimidine derivative
04/20/2006WO2005111039A3 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/20/2006US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
04/20/2006US20060084643 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania
04/20/2006US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands
04/20/2006CA2583353A1 Thienopyridinone compounds and methods of treatment
04/19/2006EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof
04/19/2006EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity
04/19/2006EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia
04/19/2006EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants
04/19/2006CN1761672A Thienopyrimidinediones and their use in the modulation of autoimmune disease
04/19/2006CN1761671A 4-aminothieno [2,3-d] pyrimidine-6-carbonitrile derivatives as PDE7 inhibitors
04/19/2006CN1761670A Novel compounds
04/19/2006CN1760197A Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers
04/19/2006CN1760196A Substituted thienothiophene monomers and conducting polymers
04/18/2006US7030250 Process for obtaining 4-(N-alkylamino)-5,6-dihydro-4H-thien-(2,3-b)-thiopyran-2-sulfonamide-7,7-dioxides and intermediates
04/18/2006US7030240 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
04/18/2006US7029606 Hyperpolarizable organic chromophores
04/18/2006CA2360943C N2-phenylamidine derivatives
04/18/2006CA2241852C Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
04/18/2006CA2207443C Tricyclic compounds
04/13/2006WO2006038222A1 AN IMPROVED PROCESS FOR THE PREPARATION OF 5,6 -DIHYDRO -4H-4(S)-ETHYLAMINO-6(S)-METHYLTHIENO[2,3-b] THIOPYRAN-2-SULFONAMIDE- 7,7 -DIOXIDE AND ITS SALT
04/13/2006WO2005120642A3 Tetrahydropyridothiophenes for treating hyperproliferative disorders